Sign In
Buy BNGO
$1.30
+0.0400 (+3.17%)
At Close: Jun 03, 2026
These 2 Penny Stocks Have Tantalizing Growth Prospects
01:45pm, Tuesday, 30'th Aug 2022 The Motley Fool
Bionano Genomics and OrganiGram Holdings are both on track for long-term success.
These 2 Penny Stocks Have Tantalizing Growth Prospects
09:45am, Tuesday, 30'th Aug 2022
Bionano Genomics and OrganiGram Holdings are both on track for long-term success.
7 Hot Growth Stocks Poised to Triple by 2030
01:55pm, Thursday, 25'th Aug 2022
This looks like a wonderful time for investors looking for hot growth stocks with very strong outlooks. I believe that the market is really starting to internalize the concept that Fed Chairman Jerome
7 Cheap Penny Stocks to Buy Before They Boom
11:47am, Friday, 19'th Aug 2022
While virtually every financial advisor will steer you away from these picks, invariably, investors eventually gravitate toward cheap penny stocks to buy. Some might end their fascination with the top
Penny Stocks To Buy Now? 4 Short Squeeze Stocks To Watch
03:17pm, Monday, 15'th Aug 2022 PennyStocks
Penny stocks to buy? Short squeeze stocks to watch this week.
The post Penny Stocks To Buy Now? 4 Short Squeeze Stocks To Watch appeared first on Penny Stocks to Buy, Picks, News and Information | Pen
It's a Tom Jones rally but it may be overbought, say analysts
10:49am, Friday, 12'th Aug 2022 MarketWatch
Nasdaq bounce off lows is not unusual but momentum indicators suggest a pause for breath
Why Is Bionano Genomics (BNGO) Stock Up 20% Today?
01:12pm, Thursday, 11'th Aug 2022
Following brewing clinical momentum, shares of Bionano Genomics (NASDAQ: BNGO ) — a biotechnology firm specializing in nanoscale imaging and analytics — soared on Thursday. This came after the com
Why Invitae Climbed Around 279%; Here Are 98 Biggest Movers From Yesterday
09:28am, Thursday, 11'th Aug 2022 Benzinga
Gainers
Invitae Corporation (NYSE: NVTA) surged 278.5% to close at $8.63 after the company reported better-than-expected Q2 EPS.
BioAtla, Inc. (NASDAQ: BCAB) jumped 83.1% to close at $6.61 on Wednesd
Bionano Genomics, Inc (BNGO) Q2 2022 Earnings Call Transcript
09:01am, Saturday, 06'th Aug 2022 The Motley Fool
BNGO earnings call for the period ending June 30, 2022.
Should You Really Be Buying Beaten-Down Growth Stocks Right Now?
02:45pm, Friday, 05'th Aug 2022 The Motley Fool
Now's a great time to invest in companies with the potential to grow significantly in the long term.
Bionano Genomics, Inc. (BNGO) Reports Q2 Loss, Tops Revenue Estimates
10:55pm, Thursday, 04'th Aug 2022 Zacks Investment Research
Bionano Genomics, Inc. (BNGO) delivered earnings and revenue surprises of -10% and 7.58%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Bionano Genomics, Inc. (BNGO) CEO Erik Holmlin on Q2 2022 Results - Earnings Call Transcript
09:14pm, Thursday, 04'th Aug 2022
Bionano Genomics, Inc. (NASDAQ:BNGO ) Q2 2022 Results Conference Call August 4, 2022 4:30 PM ET Company Participants Amy Conrad - Investor Relations Erik Holmlin - Chief Executive Officer Christopher
Bionano Genomics, Inc. (BNGO) Reports Q2 Loss, Tops Revenue Estimates
08:18pm, Thursday, 04'th Aug 2022
Bionano Genomics, Inc. (BNGO) delivered earnings and revenue surprises of -10% and 7.58%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Bionano Genomics ($BNGO) Generates Record Quarterly Revenue and Launches Version 6.2 of NxClinical
07:47pm, Thursday, 04'th Aug 2022
Bionano Genomics, a pioneer of optical genome mapping solutions, has announced second quarter results that included 73% year-over-year revenue growth as well as a 24% increase in sales of its nanochan
Anika Therapeutics (ANIK) Reports Q2 Loss, Tops Revenue Estimates
09:45pm, Wednesday, 03'rd Aug 2022 Zacks Investment Research
Anika (ANIK) delivered earnings and revenue surprises of 23.08% and 8.95%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
